AstraZeneca is committed to putting patients first. This strong focus on patients shapes how we manage all aspects of our business.
The Patient Centered Science (PCS) group plays an integral role in fulfilling this commitment by developing strategies to capture patient experience and generating impactful evidence to demonstrate the value of our medicines and support decision making by regulators, patients, physicians and payers.
We are expanding our team to include Patient Centered Science Manager to play a pivotal role in challenging our scientific capabilities to make a positive impact on changing patients lives and include patient perspective into drug development.
The role is dedicated to our Oncology therapeutic area and will require an understanding of patient-centered outcomes research within the context of pharmaceutical development.
As a PCS manager you will work closely with PCS Directors and study teams to implement Patient Reported Outcomes (PRO) and other Clinical Outcomes Assessments (COA) into clinical trials to ensure high quality evidence supporting products regulatory approval, reimbursement and commercialization.
In the role you will be driving efficient implementation of PRO into studies, with the following activities :
You will interact with internal AstraZeneca teams and externally with PRO strategic partners, linguistic validation and eCOA providers, with regulatory authorities and key external experts.
Key Accountabilities / Responsibilities
Minimum Requirements Education and Experience
Skills and Capabilities
The PCS group at AstraZeneca consist of nearly 20 persons, with a passion for including patient perspective in drug development, we are a group with diversity that enjoy leading and develop the field of patient centered science.
Do you want to work in a vibrant group this is your opportunity, send your application now!
For more information about the position please contact : Nikunj Patel, Group Director, Patient Centered Science : Oncology at nikunj.patel astrazeneca.com
Welcome with your application no later than February 9, 2020 .